Skip to content

Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion

Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00696605
Enrollment
20
Registered
2008-06-12
Start date
2008-07-31
Completion date
2009-10-31
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperosmolality, Hypoosmolality, Renal Failure

Keywords

Hypoosmolality, Hyperosmolality, Copeptin, Vasopressin

Brief summary

The are 2 principal goals in this study: 1. To measure plasma copeptin levels in healthy subjects and to correlate them with plasma AVP concentrations and urine osmolalities in iso-, hypo-, and hyperosmolar states. 2. To measure plasma copeptin concentrations in patients with chronic renal failure under the same conditions described above, in order to characterize the impact of renal function on circulating copeptin levels in correlation to plasma AVP and urine osmolality.

Interventions

None listed

Sponsors

Brahms AG
CollaboratorINDUSTRY
Hospital Centre Biel/Bienne
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* chronic renal failure grade I through IV * healthy age-matched controls

Exclusion criteria

* chronic renal failure grade V * heart failure * liver disease * nephrotic syndrome * anemia (hemoglobin level \< 100 g/L) * uncontrolled hypertension (systolic BP \> 160 mmHg; diastolic BP \> 95 mm Hg) * coexisting severe disease * known thyroid disease * known hypocortisolism * known hypercortisolism * known diabetes insipidus * pregnancy * lactation

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026